phase 3 study beginning September https://classic.clinicaltrials.gov/ct2/show/NCT05813275
looks like it’s further along than 42x.
also interesting that apnimed is a private company that has received about 200 million in venture capital.
they are also sticking to sleep apnea and not expanding into a bunch of different areas like incannex. I have to wonder why incannex wants to expand if they are so confident in 42x.
Add to My Watchlist
What is My Watchlist?